Although inhibition of C5 by neutralizing antibodies has been associated with increased risk of bacterial infection due to the inhibition of the formation of the membrane attack complex, the selective targeting of C5a/C5aR1 signaling may avoid harmful anaphylatoxin-induced effects (86, 87). This evidence concerns the gene C5AR1 and bacterial infectious disease.